CytoDyn Inc.
CYDY
$0.2926
-$0.0034-1.15%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 107.51% | 86.29% | 73.35% | 72.95% | 37.56% |
| Total Depreciation and Amortization | -37.93% | -48.57% | -50.00% | -72.09% | -83.43% |
| Total Amortization of Deferred Charges | -75.30% | -75.69% | -49.11% | -57.49% | -24.92% |
| Total Other Non-Cash Items | -87.32% | -57.42% | -35.88% | -49.20% | -52.33% |
| Change in Net Operating Assets | -238.72% | -229.85% | -251.51% | -255.92% | 1,075.56% |
| Cash from Operations | 20.19% | 62.71% | 87.18% | 94.35% | 56.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -53.51% | -42.77% | 158.21% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.42% | -52.94% | -66.04% | -62.68% | -64.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 129,812.50% | 1,439.61% | 269.68% | -- |
| Cash from Financing | -7.61% | 35.95% | -19.31% | -22.43% | -60.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.72% | 371.36% | 254.55% | 319.64% | -84.10% |